Compositions and methods for viral sensitization
US-2024360115-A1 · Oct 31, 2024 · US
US9862935B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9862935-B2 |
| Application number | US-201414770420-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 24, 2014 |
| Priority date | Feb 27, 2013 |
| Publication date | Jan 9, 2018 |
| Grant date | Jan 9, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a novel bacteriophage ΦCJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ20 (KCCM11362P) or the antibacterial composition containing the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient.
Opening claim text (preview).
The invention claimed is: 1. A method of suppressing or treating an infectious disease caused by ETEC, the method comprising: administering bacteriophage ΦCJ20 (KCCM11362P) to an animal other than human, wherein the bacteriophage ΦCJ20 comprises nucleic acid having SEQ ID NO: 1. 2. The method according to claim 1 , wherein the infectious disease is colibacillosis. 3. A method of suppressing or treating an infectious disease caused by ETEC, the method comprising: administering a composition comprising bacteriophage ΦCJ20 (KCCM11362P) to an animal other than human wherein the bacteriophage ΦCJ20 comprises nucleic acid having SEQ ID NO: 1. 4. The method according to claim 3 , wherein the infectious disease is colibacillosis. 5. A method of preparing an animal feed composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and mixing the bacteriophage composition with an animal feed base to provide the animal feed composition. 6. The method of claim 5 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the animal feed composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 7. A method of feeding an animal other than human, the method comprising: providing an animal feed composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and feeding to the animal other than human the animal feed composition. 8. A method of preparing a drinking water composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and mixing the bacteriophage composition with drinking water to provide the drinking water composition. 9. The method of claim 8 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the drinking water composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 10. A method of feeding an animal other than human drinking water, the method comprising: providing a drinking water composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and feeding to the animal other than human the drinking water composition.
Antibacterial agents · CPC title
Viruses; Subviral particles; Bacteriophages · CPC title
Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
Drugs for disorders of the alimentary tract or the digestive system · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.